JY Research Institute Inc.

Cutler Bay, Florida 33189-1230

1 studies enrolling now · 5 studies all time

What they study most

Gout, NASH - Nonalcoholic Steatohepatitis, Psychosis Associated With Alzheimer's Disease, SLE; Drug

Studies at this site

• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) — Recruiting now
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout — Completed
• Extension Study of ABP-671 in Participants With Gout — Stopped early
• Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE — Completed